NeoGenomics Inc Reports Q2 2026 Quarterly Results

What Happened
NeoGenomics, Inc. announced on July 28, 2026 that it issued a press release reporting results for its second fiscal quarter of 2026. The company furnished that press release as Exhibit 99.1 to its Form 8-K filed the same day. The Form 8-K was signed by Chief Financial Officer Abhishek Jain.

Key Details

• The press release reporting Q2 2026 results was furnished as Exhibit 99.1 on July 28, 2026.
• The company filed the Form 8-K under Item 2.02 (Results of Operations and Financial Condition).
• The filing states the furnished press release is not “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference in other filings unless expressly stated.
• The Form 8-K includes the Inline XBRL cover page data (Exhibit 104).

Why It Matters
This filing notifies investors that NeoGenomics has publicly released its quarterly earnings information; investors should review the July 28, 2026 press release (Exhibit 99.1) for revenue, earnings, guidance, and other performance metrics. Because the release is furnished (not “filed”), the legal disclosures and incorporation treatment differ from other filings, but the press release is the primary source for the company’s reported quarterly results.